Definitive Contract HHSN272201600014C
Award Date
7/1/16
Potential Completion Date
5/5/24
Potential Value
$5.8M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price contract awarded by the Department of Health and Human Services Food and Drug Administration to The Children's Hospital of Philadelphia (CHOP) on September 29, 2020. The $347,335.00 contract is for research on the incidence and outcomes of human adenovirus infection and disease among a multicenter observational cohort of pediatric allogeneic hematopoietic cell transplant recipients. The contract has a completion date of September 29, 2023 and does not have a...
The U.S. Department of Health and Human Services (HHS) awarded a $13,892,443.67 cost-plus-fixed-fee contract to The Children's Hospital of Philadelphia (CHOP) to provide HIV vaccine design and development teams for prevention and treatment. This definitive contract, awarded on August 31, 2005, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract, which does not have a set-aside designation,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $2,645,425.63 definitive contract to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) to conduct the "Natural History of Andenovirus and Related Disease in Immuncomporised Pediatric Patients" project. This contract, which does not have a set-aside designation, was issued under LBERI's parent company Lovelace Biomedical Research Institute, an expert in preclinical research services across...
This is a $276,916.98 federal contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, to The Children's Hospital of Philadelphia (CHOP) Research Institute. The contract, which is a definitive contract with cost-no-fee pricing, is for the National Children's Study. The contract does not have a set-aside designation. As a leading pediatric hospital and research institution, CHOP leverages...
The U.S. Food and Drug Administration (FDA) awarded a $87,181 firm-fixed-price purchase order contract to The Children's Hospital of Philadelphia (CHOP) to study the "Natural History of Enteroviral Sepsis Using Real World Data". The contract has an ultimate completion date of August 31, 2023. CHOP, a leading pediatric hospital and research facility, will leverage its expertise in areas such as infectious diseases to contribute to this federal healthcare initiative. The contract does...
This is a federal contract award to The Children's Hospital of Philadelphia (CHOP) from the National Institute of Diabetes and Digestive and Kidney Diseases, a civilian agency within the Department of Health and Human Services. The $18,779,641.25 definitive contract is for research and development facilities, with a period of performance ending on March 31, 2010. The contract does not have a set-aside designation. CHOP, a leading pediatric hospital and research facility, is the prime...
This is a definitive, firm fixed-price contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to The Children's Hospital of Philadelphia (CHOP) Research Institute on September 30, 2017 for a value of $322,263.00. The contract does not have a set-aside designation and is for the performance of "OTHER FUNCTIONS" with a completion date of June 30, 2019. CHOP is a pediatric healthcare provider, research institution, and...
This is a $135,193.73 firm fixed price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Children's Hospital of Philadelphia (CHOP). The contract, which does not have a set-aside designation, is for research services related to pediatric diseases and conditions, including genetic diseases, pediatric cancer, and mitochondrial disorders. CHOP, a nonprofit pediatric hospital and research center, has provided research...
This federal contract award was issued by the National Heart Lung and Blood Institute, a component of the Department of Health and Human Services, to The Children's Hospital of Philadelphia (CHOP) Research Institute. The $610,946.66 cost-plus-fixed-fee contract is for the GTRP AAV Vector Production Core Laboratory for the National Eye Institute. The contract has a period of performance from June 1, 2016 to June 14, 2017 and does not have a set-aside designation. CHOP, a leading pediatric...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $1,678,371.34 delivery order contract to Childrens Hospital Medical Center, a non-profit pediatric hospital and research center located in Cincinnati, Ohio. This contract is part of NIAID's Vaccine and Treatment Evaluation Units (VTEU) program, which supports clinical trials and research on vaccines and treatments for infectious diseases. The contract does not have a set-aside designation. Childrens...